Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry
Frank Cools, D. Johnson, Alan John Camm, Jean‐Pierre Bassand, Freek W.A. Verheugt, Shu Yang, Anastasios A. Tsiatis, David Fitzmaurice, Samuel Z. Goldhaber, Gloria Kayani, Shinya Goto, Sylvia Haas, Frank Misselwitz, Alexander G.G. Turpie, Keith A.A. Fox, Karen S. Pieper, Ajay K. Kakkar
Topics & Concepts
DiscontinuationMedicineAtrial fibrillationInternal medicineStroke (engine)Hazard ratioMyocardial infarctionWarfarinLower riskRivaroxabanCardiologySurgeryConfidence intervalMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and ManagementIntracerebral and Subarachnoid Hemorrhage Research